Sort
59,101 grants matching “hypertension”
Defensins as Melanocortin Ligands
$416,490Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2014 · DK
Defensins as Melanocortin Ligands
$416,490Carrie Haskell-Luevano · University Of Minnesota · R01 · FY2016 · DK
Fluctuations in Ionic Current Through Membrane Channels
$416,432Frederick J Sigworth · Yale University · R01 · FY2012 · NS
Dietary Fiber and Cardiovascular Inflammatory Markers
$416,429Medical University Of South Carolina · R01 · FY2004 · HL
HABS-HD - Project 1
$416,423Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · U19 · FY2023 · AG
Mechanisms regulating PKGI proteolysis and modulation of pulmonary SMC phenotype
$416,417Jesse D Roberts · Massachusetts General Hospital · R01 · FY2013 · HL
Regulation of the Endothelial Citrulline-Nitric Oxide Cycle
$416,397Duane C Eichler · University Of South Florida · R01 · FY2009 · HL
Comparative effectiveness of lipid-lowering and antihypertensive medications amon
$416,377Heidi M. Crane · University Of Washington · R21 · FY2010 · HS
Glucocorticoids, Ocular Hypertension and Glaucoma
$416,358University Of North Texas Hlth Sci Ctr · R01 · FY2005 · EY
Clinical and Translational Training Program in Pulmonary Medicine
$416,346Lorraine B Ware · Vanderbilt University Medical Center · T32 · FY2019 · HL
Renal hypoxia in the development of glomerular fibrosis
$416,338Lei Zhang · University Of Utah · R01 · FY2018 · DK
Regulation of Viscerosensory Sympathetic Reflexes: The Role of Diet-Derived Lipid Mediators.
$416,326Donal S. O'Leary · Wayne State University · R01 · FY2024 · DK
Pathological arterial muscularization and the role of integrins
$416,250Daniel Greif · Yale University · R01 · FY2016 · HL
Pathological arterial muscularization and the role of integrins
$416,250Daniel Greif · Yale University · R01 · FY2015 · HL
Epigenetic control of vascular smooth muscle in cardiovascular disease
$416,250Kathleen Ann Martin · Yale University · R01 · FY2016 · HL
Epigenetic control of vascular smooth muscle in cardiovascular disease
$416,250Kathleen Ann Martin · Yale University · R01 · FY2017 · HL
Pathological arterial muscularization and the role of integrins
$416,250Daniel Greif · Yale University · R01 · FY2017 · HL
Phosphorylation and Endothelial Nitric Oxide Production
$416,250William C. Sessa · Yale University · R01 · FY2016 · HL
Pathological arterial muscularization and the role of integrins
$416,250Daniel Greif · Yale University · R01 · FY2018 · HL
Epigenetic control of vascular smooth muscle in cardiovascular disease
$416,250Kathleen Ann Martin · Yale University · R01 · FY2014 · HL
Role of MicroRNAs 424 and 503 in Pulmonary Arterial Hypertension
$416,250Hyung Joon Chun · Yale University · R01 · FY2016 · HL
PTN, PHARMACEUTICALS (PK) AND SAFETY OF COMMONLY USED DRUGS IN LACTATING WOMEN AND BREASTFED INFANTS (CUDDLE 2.0) NETWORK
$416,211Kanecia Zimmerman · Duke University · N01 · FY2021 · HD
Lipid Binding in Obesity/Diabetes Syndromes
$416,209David A Bernlohr · University Of Minnesota · R01 · FY2010 · DK
Sphingolipid modulators of vascular growth & homeostasis
$416,162Timothy Tun Hla · Weill Medical Coll Of Cornell Univ · R37 · FY2015 · HL
Diabetic Vasculopathy and Mitochondrial eNOS
$416,162Steven S Gross · Weill Medical Coll Of Cornell Univ · R37 · FY2015 · HL